Clinical trial
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
NCT04040244
Study timeline
Study start (actual)2019-12-09Date precision: day
Registry last updated2023-10-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pneumonitisunresolved
Nonsmall Cell Lung Cancer Stage IIIunresolved
Interventions
Blood sampleOTHER
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04040244 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.